109 related articles for article (PubMed ID: 7433473)
1. The treatment of asthmatic patients using an alpha-adrenergic receptor blocking agent, co-dergocrine mesylate ('Hydergine').
Kitamura S
Pharmatherapeutica; 1980; 2(5):330-6. PubMed ID: 7433473
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
[TBL] [Abstract][Full Text] [Related]
3. [Effect of co-dergocrine mesylate on catecholamines and prolactin in elderly hypertensive patients].
Mies R; Lang R; Weidinger G; Welzel D
Arzneimittelforschung; 1983; 33(5):771-3. PubMed ID: 6683557
[TBL] [Abstract][Full Text] [Related]
4. Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by positron emission tomography.
Nagasawa H; Kogure K; Kawashima K; Ido T; Itoh M; Hatazawa J
Tohoku J Exp Med; 1990 Nov; 162(3):225-33. PubMed ID: 2091324
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
Diamant Z; Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of salmeterol in patients with allergic bronchial asthma].
Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
[TBL] [Abstract][Full Text] [Related]
7. A long-term study with co-dergocrine mesylate (Hydergine) in healthy pensioners. Results after 3 years.
Köberle S; Spiegel R
Gerontology; 1984; 30 Suppl 1():3-52. PubMed ID: 6489764
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy of nedocromil sodium in light or moderate allergic bronchial asthma].
Pacor ML; Biasi D; Lunardi C
Clin Ter; 1994 Sep; 145(9):219-22. PubMed ID: 7813168
[TBL] [Abstract][Full Text] [Related]
9. [Clinical observation of the inthal treatment of bronchial asthma].
Kosturkov G; Kirchev P; Mileva Zh; Staneva M; Slavov S
Vutr Boles; 1981; 20(4):98-102. PubMed ID: 6795829
[TBL] [Abstract][Full Text] [Related]
10. Co-dergocrine mesylate (Hydergine) and hypertensive emergencies.
Romero R; Felip A; Llibre JM; Bonet J; Caralps A
Nephron; 1989; 51(1):127-8. PubMed ID: 2915745
[No Abstract] [Full Text] [Related]
11. [Treatment of bronchial asthma with adrenergic alpha receptor blockaders].
Chachaj W; Suchnicka R; Krasnowska M; Jankowska R; Kraus-Filarska M; Panaszek B; Machaj Z
Pneumonol Pol; 1981 Jul; 49(7):511-9. PubMed ID: 6118855
[No Abstract] [Full Text] [Related]
12. Evidence for benefits of early intervention with non-steroidal drugs in asthma.
König P
Pediatr Pulmonol Suppl; 1997 Sep; 15():34-9. PubMed ID: 9316100
[TBL] [Abstract][Full Text] [Related]
13. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
Miyagawa T
Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
[TBL] [Abstract][Full Text] [Related]
14. Effects of Hydergine on platelet deposition on "active" human carotid artery lesions and platelet function.
Steurer G; Fitscha P; Ettl K; Sinzinger H
Thromb Res; 1989 Sep; 55(5):577-89. PubMed ID: 2814944
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of intravenous theophylline injection for treatment of acute exacerbations of bronchial asthma].
Inoue H; Yamauchi K; Kobayashi H; Tanifuji Y
Arerugi; 2002 Apr; 51(4):379-82. PubMed ID: 12014030
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of bronchial asthma in adults. Current advances].
Caramori G; Contoli M; Papi A
Recenti Prog Med; 2009 Apr; 100(4):171-9. PubMed ID: 19554915
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the efficacy of inhaled glucocorticosteroids in mild bronchial asthma].
Terpigorev SA; Il'chenko VA; Kol'tsun SS; Goriainov AD; Stotskaia TV; Averina TK; Paleev NR
Ter Arkh; 2003; 75(11):64-8. PubMed ID: 14708446
[TBL] [Abstract][Full Text] [Related]
18. [Physical work capacity of patients with bronchial asthma after treatment with bronchodilator agent, berotek].
Eremina SS; Solomonova LN
Sov Med; 1975 Aug; (8):141-2. PubMed ID: 793
[No Abstract] [Full Text] [Related]
19. An open multi-centre study to assess the efficacy of inhaled salmeterol in bronchial asthma in Nigeria.
Onadeko BO; Bamidele EO; Ekweani CN; Erabor GE
Afr J Med Med Sci; 1994 Sep; 23(3):301-5. PubMed ID: 7604758
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
